Bruker Launches D8 QUEST and D8 VENTURE Crystallography Systems with Novel High Intensity X-ray Sources for Structural Biology
22 August 2011 - 5:00PM
Business Wire
At the XXII Congress and General Assembly of the IUCr held in
Madrid, Bruker today launches the D8 QUESTTM and
D8 VENTURETM high performance X-ray crystallography
systems for structural biology.
D8 VENTURE for Structural Biology (Photo:
Business Wire)
The D8 QUEST is based on the new IμSTM
microfocus source, a compact and robust, yet high-performance X-ray
source. With over 200 systems installed, the IμS is already
the worldwide leader in microfocus source technology. Its new
version now features 30% higher intensity with unrivalled
reliability, backed by the industry-leading three year
warranty.
The larger enclosure D8 VENTURE features the new, high
brightness TXSTM microfocus rotating anode source, an
even stronger X-ray source which combines the advantages of the
microfocus source technology with the advantages of a rotating
anode. The TXS delivers the highest intensity available for
the home laboratory in a compact, stable and low-maintenance
package. The TXS is the first rotating anode to offer fast
and straightforward downstream alignment which allows the user to
easily and quickly align the system with the doors of the radiation
enclosure locked in compliance with the latest radiation safety
regulations. Both, the IμS and the TXS sources
deliver X-ray beams for laboratory use which are comparable in
intensity to synchrotron facilities a few years ago.
To take full advantage of these new, stronger X-ray sources the
new D8 QUEST and D8 VENTURE systems are both equipped
with the new PHOTON 100TM detector, the first CMOS
active pixel sensor (CMOS APS) based detector available on the
crystallography market. With a large active area of 10 x 10 cm2 and
the ability to run in dead time free continuous scan mode, the
PHOTON 100 satisfies the demand for large, high sensitivity
detectors and is ideally suited to replace older imaging plates or
CCD detectors.
The D8 QUEST and D8 VENTURE are equipped with the
advanced PROTEUM2 software for instrument operation and data
processing. This new and efficient collision-avoidance software
based on the latest robotic trajectory-planning algorithms makes
experiment planning easier and more efficient than ever. The
PROTEUM2 suite is easy to use for instrument control, data
collection, integration and scaling, structure solution and model
building. PROTEUM2 now features an automated pipeline for
data acquisition and integration.
Dr. Duncan McRee, Chief Scientific Officer at Omscientia and one
of the pioneers of high-throughput macromolecular crystallography,
stated: “Structural biologists will significantly benefit from the
new IμS and TXS high-brilliance, low-maintenance
X-ray sources, as well as from the speed, sensitivity and
convenience of the new large, air-cooled PHOTON 100
detector. In combination with the new automated data pipeline these
systems are ideal for sample screening and provide extremely
powerful platforms for home data collection.”
About Bruker Corporation
Bruker is a leading provider of high-performance scientific
instruments and solutions for molecular and materials research, as
well as for industrial and applied analysis. For more information
on D8 QUEST and D8 VENTURE, please visit
www.bruker.com/d8venture
For information about Bruker Corporation (NASDAQ: BRKR), please
visit www.bruker.com
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6835891&lang=en
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024